Paul Sharp

1.7k total citations
38 papers, 1.2k citations indexed

About

Paul Sharp is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Paul Sharp has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Neurology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Paul Sharp's work include Amyotrophic Lateral Sclerosis Research (8 papers), Neurogenetic and Muscular Disorders Research (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Paul Sharp is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (8 papers), Neurogenetic and Muscular Disorders Research (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Paul Sharp collaborates with scholars based in United Kingdom, United States and Spain. Paul Sharp's co-authors include Dominic J. Wells, Jason Berwick, Eva M. Kohner, Mimoun Azzouz, Keith Foster, Ian R. Graham, H M Mather, George Dickson, Viswanathan Mohan and J Lévy and has published in prestigious journals such as PLoS ONE, NeuroImage and Scientific Reports.

In The Last Decade

Paul Sharp

36 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Sharp United Kingdom 21 569 262 219 188 181 38 1.2k
Tracy D. Farr Germany 24 305 0.5× 237 0.9× 106 0.5× 267 1.4× 64 0.4× 46 1.5k
Inja Lim South Korea 20 594 1.0× 83 0.3× 259 1.2× 242 1.3× 155 0.9× 45 1.3k
Dianshuai Gao China 25 856 1.5× 189 0.7× 107 0.5× 418 2.2× 146 0.8× 125 1.8k
Hassan Azari Iran 26 680 1.2× 82 0.3× 126 0.6× 296 1.6× 307 1.7× 73 1.8k
Elena Fontana Italy 20 600 1.1× 319 1.2× 202 0.9× 160 0.9× 156 0.9× 37 1.7k
Hiroshi Mizuma Japan 23 951 1.7× 168 0.6× 268 1.2× 553 2.9× 56 0.3× 54 1.9k
Saida Ortolano Spain 22 824 1.4× 71 0.3× 524 2.4× 178 0.9× 77 0.4× 41 1.8k
Hugo Peluffo Uruguay 18 576 1.0× 416 1.6× 233 1.1× 253 1.3× 172 1.0× 39 1.5k
Debanjan Chakroborty United States 18 581 1.0× 88 0.3× 78 0.4× 338 1.8× 76 0.4× 26 1.5k

Countries citing papers authored by Paul Sharp

Since Specialization
Citations

This map shows the geographic impact of Paul Sharp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Sharp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Sharp more than expected).

Fields of papers citing papers by Paul Sharp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Sharp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Sharp. The network helps show where Paul Sharp may publish in the future.

Co-authorship network of co-authors of Paul Sharp

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Sharp. A scholar is included among the top collaborators of Paul Sharp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Sharp. Paul Sharp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharp, Paul, et al.. (2022). Graphene Oxide Nanoscale Platform Enhances the Anti‐Cancer Properties of Bortezomib in Glioblastoma Models. Advanced Healthcare Materials. 12(3). e2201968–e2201968. 14 indexed citations
2.
Sharp, Paul, et al.. (2022). The effects of locomotion on sensory-evoked haemodynamic responses in the cortex of awake mice. Scientific Reports. 12(1). 6236–6236. 8 indexed citations
3.
Yılmaz, Duygu Elif, Paul Sharp, Martin J. Main, & Peter B. Simpson. (2022). Advanced molecular imaging for the characterisation of complex medicines. Drug Discovery Today. 27(6). 1716–1723. 4 indexed citations
4.
5.
Shabir, Osman, Paul Sharp, Luke Boorman, et al.. (2020). Enhanced Cerebral Blood Volume under Normobaric Hyperoxia in the J20-hAPP Mouse Model of Alzheimer’s Disease. Scientific Reports. 10(1). 7518–7518. 12 indexed citations
6.
Boorman, Luke, Paul Sharp, Peter Redgrave, et al.. (2019). Key Aspects of Neurovascular Control Mediated by Specific Populations of Inhibitory Cortical Interneurons. Cerebral Cortex. 30(4). 2452–2464. 46 indexed citations
7.
Chandran, Jayanth, Paul Sharp, Evangelia Karyka, et al.. (2017). Site Specific Modification of Adeno-Associated Virus Enables Both Fluorescent Imaging of Viral Particles and Characterization of the Capsid Interactome. Scientific Reports. 7(1). 14766–14766. 15 indexed citations
8.
Harris, Sam, Luke Boorman, Aneurin J. Kennerley, et al.. (2017). Seizure epicenter depth and translaminar field potential synchrony underlie complex variations in tissue oxygenation during ictal initiation. NeuroImage. 171. 165–175. 8 indexed citations
9.
Tian, Xiaohe, Sophie Nyberg, Paul Sharp, et al.. (2015). LRP-1-mediated intracellular antibody delivery to the Central Nervous System. Scientific Reports. 5(1). 11990–11990. 125 indexed citations
10.
Sharp, Paul, Luke Boorman, Sam Harris, et al.. (2015). Comparison of stimulus-evoked cerebral hemodynamics in the awake mouse and under a novel anesthetic regime. Scientific Reports. 5(1). 12621–12621. 32 indexed citations
11.
Mead, Richard J., Ellen Bennett, Aneurin J. Kennerley, et al.. (2011). Optimised and Rapid Pre-clinical Screening in the SOD1G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS). PLoS ONE. 6(8). e23244–e23244. 80 indexed citations
12.
Brockington, Martin, Silvia Torelli, Paul Sharp, et al.. (2010). Transgenic Overexpression of LARGE Induces α-Dystroglycan Hyperglycosylation in Skeletal and Cardiac Muscle. PLoS ONE. 5(12). e14434–e14434. 32 indexed citations
13.
Sharp, Paul, Hema Bye‐A‐Jee, & Dominic J. Wells. (2010). Physiological Characterization of Muscle Strength With Variable Levels of Dystrophin Restoration in mdx Mice Following Local Antisense Therapy. Molecular Therapy. 19(1). 165–171. 61 indexed citations
14.
Chung, Bomee, Chiara Rapisarda, Katayoun Pourvali, & Paul Sharp. (2009). Direct effects of erythropoietin on iron absorption by human intestinal epithelial cells. Proceedings of The Physiological Society. 1 indexed citations
15.
Sharp, Paul, Mohammed T. Akbar, Sonia Bouri, et al.. (2007). Protective effects of heat shock protein 27 in a model of ALS occur in the early stages of disease progression. Neurobiology of Disease. 30(1). 42–55. 88 indexed citations
16.
Sharp, Paul, et al.. (2006). Heat shock protein 27 rescues motor neurons following nerve injury and preserves muscle function. Experimental Neurology. 198(2). 511–518. 37 indexed citations
17.
Sharp, Paul, J.R. Dick, & Linda Greensmith. (2004). The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Neuroscience. 130(4). 897–910. 57 indexed citations
18.
Sharp, Paul. (2003). Manipulating transmitter release at the neuromuscular junction of neonatal rats alters the expression of ChAT and GAP-43 in motoneurons. Developmental Brain Research. 146(1-2). 29–38. 3 indexed citations
19.
Hyer, Stephen, Paul Sharp, Marcus A. Sleightholm, Jacky M. Burrin, & Eva M. Kohner. (1989). Progression of Diabetic Retinopathy and Changes in Serum Insulin-Like Growth Factor I (IGF I) during Continuous Subcutaneous Insulin Infusion (CSII). Hormone and Metabolic Research. 21(1). 18–22. 25 indexed citations
20.
Trafford, J. A. P., et al.. (1977). Haemoperfusion with R-004 Amberlite resin for treating acute poisoning.. BMJ. 2(6100). 1453–1456. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026